The effect of alpenia galangal extract on the treatment of male sexual dysfunction caused by Selective serotonin reuptake inhibitors (SSRIs)

Investigation of the effectiveness of alpenia galangal extract on the treatment of male sexual dysfunction caused by Selective serotonin reuptake inhibitor (SSRIs)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20101130005280N41

Enrollment

Registered

2021-08-31

Start date

2021-09-16

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male sexual dysfunction caused by selective serotonin reuptake inhibitors (SSRIs). Cocaine use, unspecified with cocaine-induced sexual dysfunction

Interventions

Intervention 1: Intervention group: In this group, 30 patients with depression and anxiety under treatment with Selective serotonin reuptake inhibitors (SSRIs) for more than 6 weeks who complain of se

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient is between 18 and 60 years old No use of drugs or cigarettes

Exclusion criteria

Exclusion criteria: History of bipolar disorder, psychosis and other psychological disorders Having a medical disorder (cardiac, hormonal, respiratory etc.)

Design outcomes

Primary

Measure	Time frame
Level of depression. Timepoint: At the beginning of treatment, at the end of the second week and the fourth week after having taken the medication. Method of measurement: Beck's Depression Inventory.;Sexual dysfunction. Timepoint: At the beginning of treatment, at the end of the second week and the fourth week after having taken the medication. Method of measurement: The international index of erectile function (IIEF).;Drug side effects. Timepoint: At the beginning of treatment and at the end of the fourth week after having taken the medication. Method of measurement: Laboratory tests to assess liver, kidney and thyroid enzymes.	—

Measure

Time frame

Level of depression. Timepoint: At the beginning of treatment, at the end of the second week and the fourth week after having taken the medication. Method of measurement: Beck's Depression Inventory.;Sexual dysfunction. Timepoint: At the beginning of treatment, at the end of the second week and the fourth week after having taken the medication. Method of measurement: The international index of erectile function (IIEF).;Drug side effects. Timepoint: At the beginning of treatment and at the end of the fourth week after having taken the medication. Method of measurement: Laboratory tests to assess liver, kidney and thyroid enzymes.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Sadat Hosseinian

Mashhad University of Medical Sciences

star66h@yahoo.com+98 51 3711 2721

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026